Literature DB >> 2298613

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects.

B Maciejewski1, H R Withers, J M Taylor, A Hliniak.   

Abstract

The early responses of normal tissues of the oral cavity and oropharynx in 498 patients, and the slowly-developing responses in 268 patients who survived a minimum of 18 months after radiotherapy for squamous cell carcinoma were analyzed. The severity of acute responses correlated with dose intensity. The incidence of severe late responses increased with increase in dose per fraction and was characterized by a low alpha/beta ratio. Severe late responses were significantly associated with severe acute responses independently of dose per fraction and total dose, and were also ameliorated slightly by protraction of treatment time suggesting that some late effects were, at least partly, a consequence of acute injury. Probability of local tumor control correlated with severity of acute response, suggesting that excessive protraction of overall treatment time to minimize acute toxicity may compromise local control of the tumor. There was no demonstrable correlation between the volume of tissue irradiated and the severity of acute or late response.

Entities:  

Mesh:

Year:  1990        PMID: 2298613     DOI: 10.1016/0360-3016(90)90273-m

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  [Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].

Authors:  I A Adamietz; R Rahn; H D Böttcher; V Schäfer; K Reimer; W Fleischer
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

3.  Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction.

Authors:  Tae Hoon Lee; Joo Ho Lee; Seong Keun Kwon; Eun-Jae Chung; Hong-Gyun Wu
Journal:  Radiat Oncol J       Date:  2022-05-17

4.  Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study.

Authors:  John R de Almeida; Ryan Li; J Scott Magnuson; Richard V Smith; Eric Moore; Georges Lawson; Marc Remacle; Ian Ganly; Dennis H Kraus; Marita S Teng; Brett A Miles; Hilliary White; Umamaheswar Duvvuri; Robert L Ferris; Vikas Mehta; Krista Kiyosaki; Edward J Damrose; Steven J Wang; Michael E Kupferman; Yoon Woo Koh; Eric M Genden; F Christopher Holsinger
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

Review 5.  Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.

Authors:  C Ko; D Citrin
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

6.  DNA Damage Baseline Predicts Resilience to Space Radiation and Radiotherapy.

Authors:  Eloise Pariset; Antonella Bertucci; Margaux Petay; Sherina Malkani; Alejandra Lopez Macha; Ivan G Paulino Lima; Vanesa Gomez Gonzalez; Antony S Tin; Jonathan Tang; Ianik Plante; Egle Cekanaviciute; Marcelo Vazquez; Sylvain V Costes
Journal:  Cell Rep       Date:  2020-11-25       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.